Single-cell transcriptomics reveals FXR1 as an actionable target for siRNA therapy in ovarian cancer. - George J; Ma X; Kadamberi IP; Nair A; Mittal S; Hashemi E; Kumar S; Singh M; Geethadevi A; Pradeep M; Tsaih SW; Jorns JM; et al. (Nature communications, 2026)